This let us identify Hit1, an azolo‐imidazolidinone derivative that was able to inhibit the proteolytic cleavage of p100/RelB to p52/RelB in cultured murine kidney proximal tubular cells, a key cell target in AKI and CKD. This evidence concerns the gene RELB and chronic kidney disease.